Polyclonal Antibody to FBXO9/F-box protein 9

Date Added: April 8, 2011

Author: Stephen Jones

Researchers have indicated that they want access to novel target antibodies quickly to aid in their research. IMGENEX is therefore pleased to be able to offer researchers access to products that are not fully characterized or validated. IMGENEX IMX antibodies are shown by Peptide ELISA to bind to the peptide used as immunogen. Investigators should empirically determine the suitability of the antibody, including optimal dilutions, for other applications of interest.

  • We cannot guarantee that the IMX antibody will work in any application other than in a Peptide ELISA against the peptide used as immunogen and therefore can not offer a refund if the antibody does not work in your application.

  • IMX antibodies are offered at a lower price compared to more highly validated antibodies.

  • We are not able to provide the peptide used as immunogen for IMX antibodies.

As IMX antibodies are not fully validated we appreciate your feedback. Customer feedback is used to help generate testing methodologies which can lead to further product validation or withdrawal.

F-box only protein 9 is a Ubl conjugation pathway protein and it contains one F-box domain and one TPR repeat. FBXO9 may act as a potential sepsis biomarker or therapeutic target. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which functions in phosphorylation-dependent ubiquitination.

Antigen
Amino acids 8-25 CHSDADRVGDEGNESPAE of mouse FBXO9 protein were used as the immunogen.